You can buy or sell CYCC and other stocks, options, ETFs, and crypto commission-free!
Cyclacel Pharmaceuticals, Inc. Common Stock, also called Cyclacel Pharmaceuticals, is a clinical stage biopharmaceutical company. Read More It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.
Berkeley Heights, New Jersey
52 Week High
52 Week Low
BRIEF-Cyclacel Pharmaceuticals Receives Written Notification That Nasdaq Panel Granted Extension For Continued Listing Through June 12, 2020
March 27 (Reuters) - Cyclacel Pharmaceuticals Inc: * CYCLACEL PHARMACEUTICALS - ON MARCH 23, RECEIVED WRITTEN NOTIFICATION THAT NASDAQ PANEL GRANTED CO EXTENSI
— per share
Expected May 14, After Hours